ASRT +32% on divestiture of Glalise for $127.5M: https://www.globenewswire.com/news-release/2019/12/12/1959802/0/en/Assertio-Therapeutics-Announces-Sale-of-Gralise-for-Total-Transaction-Value-of-127-5-Million.html The buyer is Alvogen, a private company.